Gingivitis Clinical Trial
Official title:
Comparing the Effect of 0,06 % -, 0,12 % and 0,2 % Chlorhexidine on Plaque, Bleeding and Side Effects in an Experimental Gingivitis Model. A Parallel, Double Masked, Randomized, Placebo-controlled Clinical Trial
Chlorhexidine is the gold standard of dental plaque prevention, but which concentration is
the most effective is not known. The aim of the present study was to compare the plaque and
gingivitis inhibiting effect of commercial products containing 0.2%, 0.12% and 0.06%
chlorhexidine in a modified experimental gingivitis model.
In three groups of healthy volunteers, experimental gingivitis was induced and monitored over
21days, simultaneously treated with the commercial solutions containing 0.2%, 0.12% and 0.06%
chlorhexidine. The maxillary right quadrant of each individual received mouthwash only,
whereas the maxillary left quadrant was subject to both rinsing and mechanical oral hygiene.
Compliance and side effects were monitored at days 7, 14, and 21. Plaque and gingivitis
scores were obtained at baseline and day 21.
The commercial mouthwash containing 0.2% chlorhexidine resulted in statistically
significantly lower plaque scores than the 0.12 and 0.06% mouthwashes after 21 days use,
whereas no statistically significant difference was found between the effect of the two
latter mouthrinses.
A commercial available mouthwash containing 0.2% chlorhexidine proved statistically
significant better effect in preventing dental plaque than 0.12% and 0.06% solutions.
The present study was designed as a parallel, double masked, randomized, placebo-controlled
clinical trial. The experimental gingivitis model, with the modifications by Preus and
coworkers was used to induce gingival inflammation under supervised conditions throughout the
study.
The study population comprised sixty dental, medical, and dental hygienist students who
volunteered to participate in the project. A meeting was arranged for the volunteers prior to
the start of the study, through which the participants received information about oral
rinsing products in general and chlorhexidine containing products as well as information on
the study ahead, in particular.
The study period was 21 days, not comprising any special academic, religious or ethnic events
that could jeopardize the collective behavior of the study population. All information,
administration and data collection was performed at the Department of Periodontology,
Institute of Clinical Odontology, Faculty of Dentistry, University of Oslo, Norway.
The test solutions were the commercially available mouthwash products: 0.2 % chlorhexidine
(no ethanol), 0.12% chlorhexidine with 910 ppm Sodium Fluoride (NaF) without ethanol and
0.06% chlorhexidine 250ppm Sodium Fluoride (NaF). The three commercially available
chlorhexidine solutions were filled in identical, but differently labelled (A,B,C) plastic
bottles for blinding purposes.
Randomization was carried out using a computer generated random allocation table, assigning
the participants to the three study groups with 20 test subjects in each. They were all
carefully instructed to rinse for 60 sec. twice a day as recommended by the manufacturers.
Setting the baseline dental plaque score to zero was done by giving all participants a
professional tooth cleaning with rubber cup, pumice paste and dental floss at the start of
the study. The participants were given their test solution and subsequently instructed to
rinse as described above. All information was given verbally as well as in writing.
Individual plastic tooth guards had been produced to fit the teeth in the upper right
quadrant. Together with this individual tooth guard, the students were given identical
prophylaxis packs containing a medium texture tooth brush, inter-dental floss and dentifrice.
The participants were instructed to substitute their daily oral hygiene remedies with the
ones given to them, and attach the tooth guard to the tooth brush, with a provided rubber
string, before and after use so that the use of this always was remembered when using the
brush.
The participants were instructed to insert the tooth guard in the first quadrant every time
they brushed their teeth and to perform a mechanical oral hygiene routine twice daily in the
three other quadrants. They should then rinse 30 sec with tap water before and after removing
the tooth guard to remove as much as possible of the remnants of the dentifrice. Following
this procedure, the participants rinsed, as instructed, with the solution they randomly had
been assigned, repeating the procedure for 21 days. Following the scoring at day 21, the
participants received professional tooth cleaning after ending the study.
A team of five people were trained in the procedure of informing participants, receiving the
test persons for evaluation, questionnaire and clinically monitoring them. The principal
investigator and project managers managed all contact with the participants outside the
scoring room. In between appointments the project team kept in touch with the test persons by
text messaging and e-mail. The success of this service was evident by zero no-shows at the
clinic, as was the case also in the previous studies with this design.
At the interviews at day 7, 14, 21 the project managers received reports from each
participant about compliance (adherence to protocol) and verbal complaints and descriptions
of subjective side-effects. A special questionnaire had been prepared for these interviews.
Reports of ill- and side effects were carefully registered and categorized for later
statistical examination.
At day 21, the above mentioned interview was followed by an examination of clinical results.
Before entering the scoring room the project managers advised the participants to refrain
from any conversation with the scoring scientists inside. The recorders had been instructed
likewise. In the scoring room, two researchers obtained the clinical data. The Loe and
Silness plaque - and gingival index were recorded on the mesial, buccal, distal and palatal
aspects of teeth 16, 15, 14, 13 and 23, 24, 25, 26. Adverse events like discoloration
observed during the clinical examination (yes/no) and clinically visible oral mucosal
reactions were registered. In addition, plaque index by Quigley and Hine, the Turesky
modification, was registered. All clinical registrations were performed by the same
experienced periodontist, leaving her colleague to register recordings on specially designed
charts. The clinical crew was kept blind to the group allocation of the participants at all
times, as the only one that had access to the code-book was the statistician who did not
participate in the clinical events.
Statistics The present experiment aimed at comparing the plaque and gingivitis preventing
effect of the 0.12% - and 0.06% chlorhexidine solutions with the gold standard 0.2%
chlorhexidine group.
The total number of participants was 60, with 20 participants in each group. The number of
participants was based on the following power calculation. The power analysis was based on
the variable 'average plaque score in each participant'. When comparing average plaque scores
in two groups, a two-sided independent samples t-test was used, with 5% significance level.
Average standard deviation in the 3 groups was 0.40. It may be shown that in order to have
80% test power to detect a mean difference in average plaque score of at least 0.40 between
two groups, at least 15 participants must be included in each group. Because some drop-outs
were expected, it was decided to include 60 subjects in the study. Because 80% test power is
generally accepted as sufficiently high in clinical studies, and the mean difference in
mesial plaque score between group 1 and group 3 was 0.41, the above calculation suggest that
the study had acceptable test power.
When comparing mean plaque score in two groups, a two-sided independent sample t-test was
used, with a 5% significance level. When comparing proportion of subjects with a particular
adverse effect, the "linear by linear association chi-square" test was used. The statistical
analysis was conducted using the software of Statistical Package for the Social Sciences
(SPSS) for Windows, Version 16.0.
The distributions of the outcome variables were checked, and found to be sufficiently close
to the normal distribution to allow for the use of a t-test.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05568290 -
Interleukin-38 Levels in Individuals With Periodontitis
|
||
Completed |
NCT04402996 -
Meteorin-like Levels in Individuals With Periodontitis
|
||
Not yet recruiting |
NCT06016023 -
Evaluation of Macrophage Inflammatory Protein-1α as a Periodontal Disease Biomarker
|
||
Not yet recruiting |
NCT05497895 -
The Assessment of Clinical Efficacy of Topical Application of 5% Thymoquinone Gel for Gingivitis Patients
|
Early Phase 1 | |
Completed |
NCT02552589 -
Effect of Toothpaste on the Reduction of Plaque and Inflammation
|
N/A | |
Completed |
NCT02633345 -
Effects on Tablets Containing Probiotic Candidate Strains
|
N/A | |
Completed |
NCT02884817 -
Essential Oil+ELA, Plaque and Gingivitis
|
Phase 4 | |
Unknown status |
NCT01956656 -
Efficacy Of Lotus Leaves In Management Of Plaque Induced Gingivitis
|
N/A | |
Completed |
NCT02515929 -
Prospective Double-Blind Randomized Controlled Clinical Trial in the Gingivitis Prevention With OPCs
|
Phase 4 | |
Completed |
NCT02980497 -
Antiplaque/Antigingivitis Efficacy of Essential Oil Mouthrinses in Six-Month Study
|
N/A | |
Completed |
NCT02235532 -
Effects of Aloe Vera Toothpaste on Periodontal Parameters
|
N/A | |
Completed |
NCT02508987 -
Obesity and Oxidative Stress in Patients With Different Periodontal Status
|
N/A | |
Completed |
NCT01941797 -
Experimental Peri-implant Mucositis in Humans
|
N/A | |
Unknown status |
NCT01197105 -
Evaluation Study of a Mouthwash Based on Schinus Terebinthifolius to Treat Gingivitis in Children
|
Phase 1/Phase 2 | |
Completed |
NCT01593540 -
Clinical Examination of Metal Free Interdental Brushes
|
Phase 4 | |
Completed |
NCT01236963 -
Essential Oils Mouth Rinse and Dental Floss: Efficacy on Interproximal Gingivitis and Dental Plaque Accumulation
|
N/A | |
Completed |
NCT02102295 -
Effects of Antioxidant Dentifrice on Gingivitis
|
Phase 3 | |
Completed |
NCT06140784 -
A Clinical Study to Assess the Gingivitis and Plaque Effects of Various Dentifrices
|
N/A | |
Completed |
NCT02937636 -
To Investigate the Gingivitis Efficacy of a Stannous Fluoride Dentifrice in a Chinese Population
|
N/A | |
Completed |
NCT06212908 -
Assessment of Periodontal Therapy and Biofilm Management in Breast Cancer
|
N/A |